$Enliven Treateutics(ELVN)$ $Terns Pharmaceuticals, Inc.(TERN)$  $Kura Oncology(KURA)$  I’m watching a classic biotech squeeze unfold in Enliven Therapeutics $ELVN. Shares just ripped +44% to fresh 52 week highs after early Phase 1b leukemia data for ELVN-001 surprised to the upside. What matters here is context. Even after today’s vertical move, the stock is only about +2.5% y/y, which tells me this is a sentiment reset, not a late-stage blow off. A long period of dead money met with credible data is exactly how violent re-ratings start. Volume confirms it, momentum traders are pressing, and shorts are scrambling to reprice risk. This is how broken charts turn into crowded trades fast.

💊 ⓗⓐⓟⓟⓨ ⓣⓡⓐⓓⓘⓝⓖ ⓐⓗⓔⓐⓓ! ⓒⓗⓔⓔⓡⓢ, ⓑⓒ🍀🍀🍀